The prevention of bone mineral loss with hormonal replacement therapy in premenopausal dialysis women with estrogen deficiency;Hormonalna terapia zastȩpcza w zapobieganiu utracie minerału kostnego u kobiet w wieku rozrodczym z niedoborem estradiolu leczonych powtarzanymi dializami pozaustrojowymi

Polskie Archiwum Medycyny Wewnetrznej

Volumn 102, Issue 2, 1999, Pages 665-670

  Matuszkiewicz Rowińska, Joanna ^a   Skórzewska, Katarzyna ^b   Radowicki, Stanisław ^b   Sokalski, Antoni ^c   Niemczyk, Stanisław ^c   Wardyn, Kazimierz ^a   Włodarczyk, Dariusz ^a   Przedlacki, Jerzy ^a   Puka, Janusz ^c   Świtalski, Marek ^c   Ostrowski, Kazimierz ^a  

^a Pneumonologii i Alergol A M w W   (Poland)

^b AM   (Poland)

^c Osrodek Dializ Szpitala w Radomiu ^*

Author keywords

Bone mineral density; Chronic renal failure; Estradiol; Hemodialysis; Hormonal replacement therapy; Renal osteodystrophy

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ARTICLE; BONE ATROPHY; BONE DEMINERALIZATION; BONE DENSITY; BONE MINERAL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; EARLY MENOPAUSE; ESTRADIOL BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; FOLLOW UP; HEMODIALYSIS; HORMONE SUBSTITUTION; HUMAN; PREMENOPAUSE; RENAL OSTEODYSTROPHY;

EID: 0033506022     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Christiansen C., Lindsay R.: Estrogen, bone loss and preservation. Osteoprosis Int., 1990, 1, 7.
2. Malluche H.H., Faugere M.C.: Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int., 1990, 38, 193.
3. Slatopolsky E., Lopez-Hilker S., Delmez J. i wsp.: The parathyroid-calctriol axis in health and chronic renal failure. Kidney Int. 1990, 38, 41.
4. Llach F., Bover J.: Renal osteodystrophy. In: The Kidney, Ed. Brenner B.M., W.B. Saunders Company, Philadelphia, 1996, 2245.
5. Matuszkiewicz-Rowińska J.: Zmiany w układzie kostno-stawowym. W: Dializoterapia w codziennej praktyce. Red. B. Rutkowski, MAKmed, Gdańsk 1996, 328.
6. Naessen T., Persson I., Thor L. i wsp.: Maintained bone density at advanced ages after long term treatment with low dose oestradiol implants. Br. J. Obstet. Gynecol., 1993, 100, 454.
7. Felson D.T., Zhang Y., Hannan M.T. i wsp.: The effect of postmenopausal estrogen therapy on bone density in elderly women. N. Engl. J. Med., 1993, 329, 1141.
8. Lindsay R.: Hormone replacement therapy. Proceedings of IV Int. Symp. in . Osteoporosis, Honkong 1993.
9. Komm B.S., Terpening C.M., Benz D.J.: Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science, 1988, 241, 81.
10. Erikssen E.F., Colvard D.S., Berg N.J.: Evidence of estrogen receptors in normal human osteoblast-like cells. Science, 1988, 241, 84.
11. Silver J., Epstein E., Naveh-Many T.: Oestrogen deficiency - does it have a role in the genesis of skeletal problems in dialysed women? Nephrol. Dial. Transplant., 1996, 11, 565.
12. Riggs B.L.: Formation-stimulating agents other than sodium chloride. Proceedings of IV Int. Symp. in osteoporosis. Honkong, 1993.
13. Naveh-Many T., Almogi G., Livni N., Silver J:. Estrogen receptors and biologic response in rat parathyroid tissue and C-cells. J. Clin. Invest., 1992, 90, 2434.
14. Silver J., Naveh-Many T.: Regulation of parathyroid hormone synthesis and secretion. Semin. Nephrol., 1994, 367, 284.